Health Archive » October, 2026

Health - October, 2026

378 articles

• EssilorLuxottica Keeps Eyewear Antitrust Win At 2nd Circ.
• Teva, AbbVie To Face Trial Over Niaspan Pay-For-Delay Claims
• Hospital In 'Maya' Case Acted In Good Faith, Fla. Court Told
• Pension Plan Says Denver Health Is Delaying $2M In Payments
• 'Why Would I Deceive You?': Fact-Checking The Holmes Doc
• States Say Trump Can't Limit Funding Freeze Injunction
• Massachusetts And Idaho To Vote On Restricting Cannabis
• DEA Begins Registering Hundreds Of Marijuana Dispensaries
• AGs Seek Final OK For $29.6M Glenmark Price-Fixing Deal
• Ohio Judge Strikes Down Remainder Of 6-Week Abortion Ban
• Indian Health Nonprofit Can't Avoid HHS Repayment Demand
• Records Ordered In Doctor's Suit Against WWE Accuser's Atty
• 3 Firms Guide Pair Of Biotech IPOs Raising $310M
• Cigna Patients Seek Hefty Class In Cigna Auto Denials Suit
• Defending Hospital Antisteering Clauses From DOJ Scrutiny
• How AI Could Help Judges Spot Their Own Biases
• Polsinelli Adds ArentFox Schiff Healthcare Litigator In DC
• Botox Exempt From Medicare Price Talks, Judge Rules
• 3 Ways Burgeoning AI Use Can Trip Up Benefits Providers
• Philly Health System's Time Rounding Shorted OT, Suit Says
• Home Care Cos. Win Partial Block Of DOL Overtime Rule
• Judge 'Put Off' By Atty Fee Bid In $59.5M Menstrual App Deal
• Colo. Justices Won't Review Hospital's Injunction Compliance
• Judge Rejects 'Kitchen Sink' Protest Of Optum DHA Deal
• GEO Says Colo. Health Inspection Law Suit Should Survive
• EMT Immunity Doesn't Cover Driving, Wash. Justices Say
• Pa. Supreme Court OKs Cancer Misdiagnosis Retrial
• Fertility Cos. Accused Of Moving Eggs Without Consent
• Squires Grants 4 Patent Review Bids In Latest Bulk Order
• Delaware Chancery Keeps $8.9B R1 RCM Buyout Claim Alive
• Judge Rejects Extra Hurdle For Medicaid Frailty Exemption
• Pot Use Firing Suit Can Be Arbitrated Despite Flawed Clause
• Pa. Court OKs Unemployment Comp Despite Off-Duty Lie
• What Expanded CMS Authority Means For Health Compliance
• DOL Finalizes Pharmacy Benefit Manager Fee Disclosure Rule
• Product Liability's Regulatory & Legislative Recap So Far
• TB Outbreak In Wash. Prisons Yields $52M Damages Verdict
• Patients Seek OK Of Connecticut Rehab Data Breach Deal
• Ga. University System On Hook For $3M In Child Death Suit
• Patients Tell Colo. Justices Hospital Defied Gender Care Order
• Cannabis Event Founders Accused Of $750K Fraud
• Cruise Co. Settles Fla. Doc's Whistleblower Suit Over Billing
• New Manhattan DA Task Force Puts Antitrust In Its Crosshairs
• Pharma Co. Settles Workers' 401(k) Forfeiture Suit
• NJ Health System Hit With Class Action Over Retirement Plan
• BakerHostetler Malpractice Case To Expand With RICO Claim
• Sanofi Settles Insulin Pen Antitrust Suit, Avoiding Trial
• Celgene Defends Dismissal Of Cancer Drug Antitrust Suit
• 4th Circ. Judge Wary Of NC Abortion Drug Law Challenge
• 3 Strategies To Reduce AI Sycophancy In Legal Work
• Mass. Hospitals Sue Lilly Over 340B Discount Data 'Extortion'
• 3 Federal Circuit Clashes To Watch In November
• Milliman Reaches $15.5M Deal In Life Insurance FCRA Suit
• OpenAI Sued Over Epilepsy Death Allegedly Tied To ChatGPT
• CVS Says Faulty Medicare Advantage Ratings Will Cost It $2B
• Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More
• Feds Settle Suit Over Botched Atlanta VA Hysterectomy
• Deal In NFL 'Race-Norming' Benefits Suit Gets Final OK
• Judge OKs Omnicare Asset Sale, Ch. 11 Loan Changes
• ​​​​​​​Drugmakers Seek To Bar 'Big Pharma' Label In Price-Fix Trial
• DOJ Directive Gives Contractors A Fraud Risk Road Map
• NC Health Plan, Atrium Settle Spat Over Cost-Sharing Program
• Ga. Children's Hospital System Hit With Time-Shaving Suit
• Meta Docs Reveal Plan To Discredit Teen-Harm Critic Haidt
• Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit
• Feds Say States Lack Standing To Sue Over HHS Vax Overhaul
• Colo. AI Rules Face Calls For Longer Compliance Window
• Pa. Court Affirms $9.5M Verdict Over Botched Vasectomy
• Nomi Says HHS Shirked COVID Care Reimbursement Promise
• Blue Cross Says National TM Link Dooms Ford Antitrust Suit
• Soul BnB Says Airbnb Didn't Properly Serve TM Case
• Colo. Staffing Cos. Settle Travel Nurses' OT Suit For $7M
• 3 Firms Steer Obesity Drugmaker Corxel's $377M SPAC Deal
• Immigrant Detainees Say ICE Is Defying Clean Facility Order
• In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th
• Whistleblower 'Gold Rush' Might Strain DOJ, Experts Warn
• Bristol-Myers, Others Appeal Revlimid MDL To 3rd Circ.
• 2nd Circ. EFAA Ruling Shifts Employer Litigation Strategy
• 6 Firms Steer $5.7B Surgery Partners Take-Private Deal
• Mich. Panel Backs $9.7M Negligence Verdict Against Hospital
• Texas Couple Sent To Prison For Medicare Fraud Scheme
• Radiology Co. Strikes Deal In ESOP Fight Ahead Of Trial
• Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed
• 5th Circ. Revives Facebook Users' Eyemart Wiretap Suit
• Consumers Fight Bids To End Delta-8 Mislabeling Suit
• J&J Wins Ohio Talc Mesothelioma Trial
• Del. Forum Selection Clause Sinks IQVIA's NC Poaching Suit
• Baxter Says Novum Pump Issues Don't Show Securities Fraud
• EEOC Suit Over Yale's Age-Based Doc Testing Headed To Trial
• 1st Circ. Says Sinovac Investor's Fraud Suit Came Too Late
• NC Asks 4th Circ. To Undo Atty Fees In Prison Trans Care Row
• Geico Says Fla. Cos. Owe $4M For Fraudulent Billing Scheme
• Fenwick, Cooley Steer Lycia Therapeutics' Upsized $318M IPO
• Telemed Co. Owner Gets 20 Years For $46M Medicare Scheme
• More Info Needed To Back Up Conduent $80M Breach Deal
• 3rd Circ. Ruling Opens Door For Fraud-On-The-Market Rethink
• Taxation With Representation: Milbank, De Brauw, Wachtell
• Crowell & Moring Hires 10-Year DOJ Healthcare Litigator
• Insurer Can't Exit Captive Carrier Fight, NC Justices Rule
• Hims & Hers Says Privacy Policy, Disclosures Foil FTC Suit
• Nurse Says NY Health System Forced Pregnancy Leave
• DOJ Tackles Largest-Ever Sham Drug Treatment, Other Frauds
• DEA Judge Will Not Reopen Marijuana Rescheduling Hearing
• Zimmer Biomet Can't Slip Sales Rep Kickback Claims
• Gilead Reaches $45M Settlement To End Kickback Claims
• Full 9th Circ. Won't Review Surgical Robot Antitrust Fight
• J&J Says Justices' Denial Backs Tossing Fee Suit At 3rd Circ.
• Mylan Settles Connecticut's EpiPen Price Claims For $8M
• NJ Panel Lets Nursing Home Arbitrate Resident Death Suit
• Judge Says BCBS' Evidence Ask In Ford Case Too Late
• Hospital Tells DC Circ. Talks Tainted Nurses Union Election
• CMS Hit With Another Broker Suit Over ACA Registration Bar
• 'Substantially Impaired' Main Topic Of Medicaid Rule Hearing
• Being In The Peace Corps Made Me A Better Lawyer
• 7 Firms Advise EQT, Qiagen On $12.1B Take-Private Deal
• Reckitt Benckiser Denies Firing Manager For Whistleblowing
• Ill. Judge Questions Bid To Block 340B Drug Discount Law
• 9th Circ. Judges Hint Hospital CBA May Mandate Arbitration
• PBM Fee Disclosure Rule Clears White House Review
• 4 Firms Steer Cencora's $2.4B American Oncology Acquisition
• Linde Seeks $1.2M Clawback From Exec Who Joined Rival
• Intuitive Surgical Strikes $450M Deal In Robot Antitrust Suit
• Amarin Ends 'Skinny Label' Patent Case Against Hikma
• Squire Patton Lands Akerman's Public Finance Co-Leader
• Pa. Panel Sets 3-Year Limit On Minimum Wage Claims
• Wachtell Lipton Guides Abbott Nutrition Spinoff
• SEIU Fired Organizer Over Military Leave, Suit Says
• High Court Lets Block On Prison Gender Care Ban Stand
• Feds Offer Up-Front Payments For Fraud Whistleblower Tips
• Metabase, Pediatric Telehealth Biz Sued Over Patient Info Leak
• Medical Device Co. Beats Investors' Alleged Demand Drop Suit
• Meta To Rereview MDL Privilege Claims Under Special Master
• Medtronic Sued Over Insulin Pump Failures
• 11th Circ. Rejects Ex-3M Worker's COVID Vax Refusal Suit
• Mich. Pharmacist Tells 6th Circ. Feds Silenced Key Witness
• 2nd Circ. Won't Block Connecticut Drug Price Cap
• Comcast Says Workers Can Avoid Tobacco Surcharge  
• A Nuanced Reading Of DOL's Mental Health Parity Guidance
• REIT Says Narcan Dispenser Spiked Crime Near Apartments
• 7th Circ. Rejects Removal Of Hospital Patient Privacy Suits
• Ill. Lab Owner Charged Over $66M COVID-19 Test Fraud
• OB-GYN Not Covered In Abortion Mishap Suit, Insurer Says
• Polsinelli Seeks Sanctions For 'Knowingly False' IP Suit
• LA Tells 9th Circ. DOJ Pot Shift Can't Revive License Appeal
• 6th Circ. Spotlights Cannabis Contract Enforceability Risks
• CMA Seeks Views On Intersurgical's Teleflex Deal
• Freshfields Hires Gibson Dunn Life Sciences Lawyer In DC
• 95K Contact Lens Buyers Nab Cert. In Hubble Substitution Suit
• FCC Report Says Tribes Lack Funding For Suicide Hotline
• 23andMe Successor Co. Inks $6M Data Breach Deal With Calif.
• 5 Firms Build Migraine-Focused TriGemX's $600M SPAC Deal
• Port Of Seattle Challenges Trump Grant Terms Targeting DEI
• Pot Co. Ascend Says It Had Good Reasons To Fire Executive
• Accused In $91M Health Plan Scam Asks To Halt FTC Suit
• Mass. Court Affirms Doctor's Partial Win Over Insurer
• Prior 5th Amendment Pleadings Complicate Mylan Testimony
• Biz Groups Back Health System's Win In 401(k) Forfeiture Suit
• DOJ Appeals New Trial Order In Ex-NFL Player's Fraud Case
• A Day In The In-House Life: CHAI GC Talks Balance
• Where DOJ's Fraud Directive May Actually Affect Enforcement
• Conduent Inks $80M Breach Deal With 62M Class Members
• 2nd Circ. Denies Rehearing In Tylenol Autism Suits
• NY, Conn. Secure $2.7M Deal Over Health Network Data Breach
• Suing The Trump Admin Can Have Massive Impact, Attys Say
• NY Nursing Home Hit With $6.8M Verdict In Understaffing Case
• Hospital Operator Challenges NC AG's Power Over Merger
• Device Co. Accused Of Shorting Co-Founder's Payments
• FTC Wants More Info On $350M Surgical Supplies Deal
• City Therapeutics' Upsized $200M IPO Joins Biotech Wave
• Could A Criminal Sentencing Case Upend Loper Bright?
• States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal
• Aetna Drops Medical Billing Suit Against Acupuncture Clinic
• Conn. Doctor Settles Fraud Claims Over COVID Test Billing
• Former Connecticut Budget Boss' 2nd Bribery Trial Delayed
• China Tightens Export Controls On AI, Biotech Technologies
• Brokers Sue CMS Over Moratorium On ACA Registration
• 'Defend To The End': Atty Admits Error In Gucci Glasses Suit
• Taxation With Representation: Freshfields, Morgan Lewis
• 11th Circ. Backs Florida Firm In Lender Note Verdict Appeal
• Mich. Panel Says PIP Opt-Out Bars State Medical Coverage
• Healthcare VP Gets 18 Months In $450M Medicare Scheme
• Expect These Post-Midterm Probes If The Hill Changes Hands
• FTC Hospital Review Shows Hurdles To Failing-Firm Defense
• Mayer Brown Lands 2 Sheppard FDA Partners
• Ex-NFL Player Seeks $300M Over Career-Ending Hip Surgery
• Audiologists Sue RFK Jr. Over Medicare Opt-Out Exclusion
• Texas Appeals Court Says Perot VC Suit Belongs In Biz Court
• OptumHealth Can't Get Out Of PBM Cases In Opioid MDL
• Optum Sued Over 'Junk Fees' For Online COBRA Payments
• Trump Admin Urges High Court To Curb APA Rule Vacatur
• Feds Seek To Undo Colo. Payment To Defunct Health Insurer
• Importer Risk Rises As AI Enters Trade Fraud Enforcement
• OrbiMed Closes 2 Latest Funds With Combined $3B In Tow
• What CMS Audit Rule Means For Medicare Advantage Plans
• Medical AI Platforms Report Settlement Amid Discovery Battle
• PhRMA Again Seeks To Join 340B Rebate Pilot Fight
• Parsing The Latest Signals On FTC Section 5 Enforcement
• Medical Practice Says Coverys Owes Defense In Abuse Suits
• Calif. Pot Shop Escapes Suit Over Alleged Gummy Reaction
• Genentech Wins Judge's OK Of $18M Novartis Award
• NC Health Plan Can't Block Atrium's Cost-Sharing Program
• 2nd Circ. Skeptical Of Reviving $4.4M 'Multiplex' COVID Suit
• Cannabis Reform Foes Cite GAO In Push To Reopen Hearings
• Anthropic Seeks To Dodge AI Patent Suit From U. of Tenn.
• Panel Won't Revive Doctor's MedMal Suit Against Emory
• Ex-Prosecutor To Lead Meland Budwick Health Law Practice
• Manhattan DA Unveils Corporate Crime & Antitrust Task Force
• Why Vaccine Court Inoculates Drugmakers Against Litigation
• Fox Rothschild Beats Daycare's Malicious Prosecution Suit
• Healthcare CEO Gets 19 Years In $450M Medicare Scheme
• Genesis Healthcare Gets Approval For Liquidation Plan
• Sanofi Agrees Not To Disparage Rival's Flu Vaccine
• What Lawyers Should Know Before Accepting Crypto Payment
• IRS Proposes To Block Immigrants From Premium Tax Credit
• 7-Eleven To Pay $2.3M To Resolve Tobacco Fee Fight
• Liquidia Settles United Therapeutics Suits With $380.7M Deal
• Skadden Adds 5 DLA Piper Mass Torts Attys To Chicago Office
• Feds' Mich. SNAP Records Fight Paused Pending Calif. Ruling
• Mommy's Bliss Melatonin Isn't Safe For Kids, Suit Says
• Island Golf Club And Hospital Sued After Wasp Sting Death
• Ex-U. Of Fla. Urologist Can't Get Sex Bias Suit Back On Track
• CVS Reaches $315M Deal With DOJ Over Opioid Prescriptions
• Denver Health Hit With Wage Suit Over Off-The-Clock Work
• Justices Won't Review Arbitrator Bias In Nursing Home Suit
• CarePoint Owes 401(k) Payments Post-Ch. 11, Union Says
• Jones Day, Morgan Lewis Guide $2.1B Steris-Xodus Deal
• Troutman Grows Life Sciences Litigation Group In Philly, NY
• 1st Circ. Revives Amgen Migraine Drug Risk Label Suit
• Haynes Boone Launches In San Diego For 4th Calif. Location
• Health Co. Mirra-Access Hits Ch. 11 To Deal With $400M Loan
• What To Know As State 'Neural Data' Privacy Laws Emerge
• Dentons Adds K&L Gates Lawyer To Healthcare Practice In DC
• McDermott Hires Ex-Greenberg RE Atty For NYC Office
• Laid-Off Workers Can't Sue Amid Board Appeal, Feds Say
• DOJ Aims To 'Attack Fraud From All Angles' Via New Division
• TRex Bio Leads 2 Drugmakers Pricing IPOs Totaling $162M
• Expert's Failure To Identify Doctors Dooms Texas Med Mal Suit
• 9th Circ. Says AmeriBen Data Breach Enough To Allege Injury
• Gene Therapy Patent Suit Against Sarepta Comes To Close
• DA Pans Mangione's Double Jeopardy Bid In NY Murder Case
• Estate Says Insurer Must Cover Fatal Hyperbaric Chamber Suit
• Woman Says Emory Healthcare's Inaction Led To Son's Death
• Latham-Led Consonance Clinches $1.35B Healthcare Fund
• 'A Moral Hazard': Kalshi Drug Trial Bets Spark Ethical Qualms
• Logistics Cos. Can't Pause Tobacco Fee Suit
• ERISA Recap: 6 Notable Decisions From September
• Feds Again Turn To 9th Circ. In Fight Over ICE Facility
• Squires Grants 4 PTAB Petitions, Rejects 3 In New Drop
• Eli Lilly Lobs 4 Suits Alleging Illegal Weight Loss Drug Sales
• IVF Genetic Test Class Can't Prove Inaccurate Results
• Hospitals Ask Court To Block Revised Plan For 340B Rebates
• Health Plan Takeaways After 2nd Circ. No Surprises Act Ruling
• Taro Pharma Says MDL Deal Bars States' Duplicative Claims
• Texas Clinics Settle False COVID-19 Billing Claims For $20M
• Wash. Justices Say Privacy Act Doesn't Bar Hospital Pixel Use
• Mayne, Ascend Cut $1M Generic Price-Fixing Deal With States
• Pa. Justices Urged To Toss $207M UPenn Med Mal Verdict
• High Court Urged To Keep Prison Trans Care Ban Blocked
• Mich. Says Blue Cross Monopoly Ups Costs And Cuts Care
• Flint Hospital Accused Of Race Bias In Nurse Promotion
• $13.4M Conn. Insurance Fight Won't Resume Amid Appeal
• 2 More Sentenced In $11M Amtrak Health Fraud Scheme
• Kirkland-Led Aphias Wraps Inaugural Fund At $1.05B
• Genesis Healthcare Gets OK For Amended $1B Asset Sale
• Viatris To Buy Pacira BioSciences For $1.65B
• IDScan Data Breach Puts Spotlight On Vendor Oversight
• FDA Expects Mifepristone Safety Review Results By March
• New Fraud Division Flexes Might In Latest Enforcement Policy
• Benefits Co. Wants Sanctions For 'Frivolous' TCPA Suit
• Blinded Yale Patient Wants $6.6M On Top Of $15.1M Verdict
• Mentalism Makes Me A Better Lawyer
• Humana Brass Face Derivative Suit Alleging Illegal Kickbacks
• 2nd Circ. Spikes Yale Health Workers' Vax Mandate Challenge
• Blue Cross Must Justify Carve-Up Unit By Unit In Calif.
• Eldercare Co.'s Wage Class Fight Bound For Wash. High Court
• JPML Consolidates Nevro, Abbott Spinal Cord Device Suits
• Ark. Panel Says Insurers Must Defend Walmart Opioid Suits
• PhRMA Sues To Block Medicare Foreign Drug Price Rule
• 1st Circ. Seems Torn On DOJ Bid For Trans Care Records
• 3rd Circ. Upends Sandoz's $61.6M Award Against UTC
• NC Hospital Accuses Blue Cross Of Refusing Covered Claims
• Why And How To Build A Neurodiversity-Informed Practice
• Ga. Appeals Court Grapples With Nurses' COVID-Era Pay Fight
• Utah Cannabis Shop Says NLRB Case Can't Be Tossed Yet
• CVS 401(k) Recordkeeping Fee Suit Dropped In New York
• Arnall Golden Adds Ex-CMS Leader To Healthcare Team In DC
• Prosthetic Breast Merchant Admits To $1.3M Insurance Fraud
• BCBS Unit Owes Awards Under No Surprises Act, Court Told
• Kirkland-Led Sheridan Secures $1.345B For 2 Latest Funds
• Mich. Judge Questions Push To Revive Abortion Restrictions
• AstraZeneca Takes Drug-Pricing Law Challenge To 4th Circ.
• CVS Can't Get Second Shot At Tossing Investors' AI Use Suit
• NC Biz Court Bulletin: Monopoly Suit Setback, Historic Deal
• Neurosurgeon Group Says It Fixed Anthem Unit Antitrust Suit
• 1st Circ. Sees Gaps In Order Halting RFK's Vaccine Advisers
• Colo. Hospital Employee Asks For Class Cert. In OT Suit
• Anthem BCBS Accused Of Failing To Reimburse 7 Hospitals
• FDA Accuses 10 Retailers Of Selling Unapproved STI Meds
• Dentists Can't Avoid Delta Dental MDL
• Texas Justices To Review Law Firms' Paxil Fees Fight
• AG Watch: Texas Takes A Lone State Stand Against Tech Cos.
• Contact Lens Rule's Evolution Steers FTC Guidance Program
• 4 Firms Advise On $5.8B Option Care Health Take-Private Deal
• Justices Won't Hear Ex-Theranos Exec's Conviction Challenge
• 7th Circ. Judge Hints Precedent Dooms Worker's Vax Fight
• Pharma Sales Rep. Says Taking Cancer Leave Got Him Fired
• Air Ambulance Co. Says Pilot's 'Inattention' Wasn't Willful
• Boston Health Worker Says Firing Followed Fraud Concerns
• Verogen Genealogy Website Can't Escape DNA Privacy Suit
• Masimo's $634M Apple IP Win Boosted By $184M In Interest
• 9th Circ. Revives Antitrust Suits Against Invisalign
• 5th Circ. Hints CMS Medicare Advantage Rule May Violate APA
• Securities Roundup: 7 Rulings You May Have Missed
• 5th Circ. Backs Surgical Stapler Death Suit Dismissal
• Justices Mull Courts' Authority To Hear Vets' Benefits Suit
• Catholic Org. Funding Cut Wasn't About Faith, Mich. Says
• 'Shocking' COVID Vaccine Appeal Meets Skeptical 2nd Circ.
• Inspired Healthcare Gets OK For $713M Sale
• High Court Won't Review Medical Tape Antitrust Case
• Worker Fired After Flu Vax Rift Can't Get High Court Traction
• Chancery Allows Discovery In Boehringer Trade Secrets Fight
• Groups Ask DC Circ. To Revive CMS Hemp Program Case
• 1st Circ. Doubts Harvard Grant Fight Belongs In Claims Court
• Drug Discounter's $48M Arbitration Award Tossed For Fraud
• Justices Want SG's View On 3 Antitrust Cases
• Feds Aim To Improve Health Cost Clarity With Final Reg
• Abbott FCA Deal Shows Enforcement Adequacy Quandaries
• Justices Won't Review Pregnancy Center Vandalism Case
• High Court Won't Hear Chicago Workers' Vaccine Appeal
• Justices Pass On Challenge To New York Diet Pill Law
• Justices Won't Hear Minn. Indian Child Welfare Act Case
• Supreme Court Won't Take Up DOD Workers' Vax Bias Suit
• Justices Reject Deportation Risk Advice Case
• Up First At High Court: Climate Torts & Munitions Disposal
• Teva Ruling Creates Medicare Drug 'Chaos,' Full DC Circ. Told
• Pa. Justices Reject Federal Limits On Agency Deference
• Judge OKs Provider Not Telling Clients Of Deal End, For Now
• Staffing Co. To Pay Colo. $2.86M Over False Travel Bills
• Medivis Gets Some AR Device Patent Claims Cut In Remand
• Fla. Firm Knew It Had To Secure Lender Notes, 11th Circ. Told
• NY-Presbyterian Can't Nix Union Funds' Antitrust Suit
• Pa. Hospital Workers Sue Over Biased Time Rounding
• DOJ Envisions 'Full-Fledged Law Firm' To Combat Gov't Fraud
• Nurse Says Emory Offered Laundry Work After Light Duty Bid
• New DNA Screening Standard Has No Clear Playbook
• Nurse Can't Get 9th Circ. To Reopen COVID-19 Vax Bias Suit
• 6th Circ. Blocks 100s Of Opioid MDL Cases Targeting PBMs
• States Seek OK Of $400M Sandoz Generic Price-Fixing Deal
• Greenberg Traurig Adds Food, Drug Law Atty In DC
• Roberts Wants Less Talk. Supreme Court Attorneys Disagree.
• Miller & Chevalier Adds Former DOJ Healthcare Fraud Leader
• Class Cert. Denied In Planned Parenthood Tracking Tech Suit
• 5 Supreme Court Cases To Watch This Fall
• 4 Argument Sessions Benefits Attys Should Watch In October
• Calif. Gov. Pushes For More In Signing Bill Limiting CIPA Suits
• Home Health Co. Seeks Pause Of Colo. Agency's Backout
• Patients' Texas Anesthesia Rollup Suit Trimmed
• AbbVie Gets Humira Antitrust Suit Trimmed, But Not Tossed
• NH Families Seek To Block Medicaid Ban On Youth Trans Care
• Fed. Circ. Won't Rethink Vacating Contractor's $12.7M Award
• Wounded Cop Can't Sue Philly Hospital Over Shooting
• Hospital Can't Privately Contact Ex-Docs, Wash. Justices Rule
• Judge Bars HHS Medicaid Cuts For Wash. Noncitizens On SSI
• Fla. Doc Says He Opposed Cruise Co.'s Billing, Got Fired
• Liquidia's Yutrepia Found To Infringe Lung Treatment Patent
• Ex-Actavis Exec Escapes Some Drug Price-Fixing Claims
• Aya Health Tells 9th Circ. It Needn't Seek Suits Against Itself
• Calif. Judge Vacates Trump's $100K H-1B Fee Policies
• Fed. Circ. Backs Galderma In Injection Training IP Case
• Texas Medicaid Fraud Decision Leaves 2 Open Questions
• Walgreens Closes In On $9B Boots Sale, Plus More Rumors
• Janssen Biotech Beats Kickback Suit Over Advice To Docs
• Calif. Co. Will Pay $20M To Settle COVID Payment Claims
• Buchalter Data Breach Exposed Calif. Hospital Patient Data
• FBT Gibbons Beats DQ Bid In Suit Over Cigna Payments
• Testing AI's Promise For Large-Scale Document Review
• Trump Announces Judicial Noms For 5th Circ., NC
• DOJ Outlines New Corporate Fraud Enforcement Priorities